STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATRC
  4. [Form 4] AtriCure, Inc. Insider Trading Activity

AtriCure (ATRC) CFO granted 63,088 shares and transfers stock for taxes

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AtriCure, Inc. reported equity award activity for Chief Financial Officer Angela L. Wirick. On March 1, 2026, she acquired 39,987 shares of common stock through a restricted stock award under the 2023 Stock Incentive Plan, which will vest in three equal annual installments. She also acquired 23,101 shares from the vesting of a performance share award after company performance goals and service requirements were met. To cover tax withholding from these vestings, she disposed of 22,965 shares back to the company at $31.26 per share, leaving her with 204,893 directly owned shares of common stock.

Positive

  • None.

Negative

  • None.
Insider Wirick Angela L
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Common Stock 39,987 $0.00 --
Grant/Award Common Stock 23,101 $0.00 --
Tax Withholding Common Stock 22,965 $31.26 $718K
Holdings After Transaction: Common Stock — 204,757 shares (Direct)
Footnotes (1)
  1. The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wirick Angela L
(Last) (First) (Middle)
7555 INNOVATION WAY
(Street)
MASON OH 45040-9695
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2026 A 39,987 A $0(1) 204,757 D
Common Stock 03/01/2026 A 23,101 A $0(2) 227,858 D
Common Stock 03/01/2026 F 22,965(3) D $31.26 204,893 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
2. The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
3. The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.
Remarks:
/s/ Angela L. Wirick 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did AtriCure (ATRC) report for Angela Wirick?

AtriCure reported that CFO Angela Wirick received two stock awards totaling 63,088 shares and transferred 22,965 shares back to the company for tax withholding. All transactions involved common stock under the 2023 Stock Incentive Plan.

How many AtriCure (ATRC) shares did the CFO acquire in the latest Form 4?

Angela Wirick acquired 39,987 restricted shares and 23,101 performance-based shares of AtriCure common stock. These grants were made under the company’s 2023 Stock Incentive Plan after meeting vesting conditions and performance goals described in the filing footnotes.

Why did AtriCure’s CFO dispose of 22,965 shares of ATRC stock?

Angela Wirick transferred 22,965 shares back to AtriCure to satisfy tax withholding obligations arising from vesting of prior restricted and performance share awards. This tax-withholding disposition used a price of $31.26 per share, according to the Form 4 details.

What is Angela Wirick’s AtriCure (ATRC) share ownership after these transactions?

Following the reported grants and the tax-withholding share transfer, Angela Wirick directly owns 204,893 shares of AtriCure common stock. The Form 4 lists this figure as the total number of shares held directly after the March 1, 2026 transactions.

How do AtriCure (ATRC) restricted stock awards to the CFO vest?

The Form 4 states that 39,987 restricted shares granted to Angela Wirick vest in three equal annual installments. One-third vests on each of the first, second, and third anniversaries of the March 1, 2026 grant date, subject to continued service.

What conditions applied to AtriCure (ATRC) performance share awards granted to the CFO?

The 23,101 performance shares that vested for Angela Wirick were subject to company performance goals and a service period requirement. The filing notes these conditions were satisfied, triggering the vesting and release of the performance share award under the 2023 plan.